VLS does not indicate a different peptide It is an identifier used for reference and documentation purposes
Animal studies have shown potential risks with GLP-1 drugs during pregnancy, and these medications should be discontinued before conception if possible
store without an injection needle attached
What makes GLP-1s particularly sophisticated is their glucose-dependent action they only stimulate insulin when blood sugar levels are elevated, minimizing hypoglycemia risk
A strong letter of medical necessity should include: your BMI history over at least 12 months, documentation of weight-related comorbidities (hypertension, type 2 diabetes or prediabetes, dyslipidemia, sleep apnea), prior weight-loss attempts and their outcomes, the specific clinical trial data supporting the requested medication, and a statement that the medication is medically necessary (not cosmetic)